Enhancing Precision Medicine: How Multigene Assays Help Shape Treatment Strategies
Please join us for our industry satellite symposium during ESMO Breast Cancer 2025 on Friday, May 16th, 2025.
Event details
ESMO Breast Cancer 2025 Industry Satellite Symposium
Enhancing Precision Medicine: How Multigene Assays Help Shape Treatment Strategies
When
May 16th, 2025
12:15–13:15 CEST
Where
Room 5, ICM – International Congress Center Messe Munich
Speakers
Chair
Agaplesion Markus Hospital, Frankfurt, Germany
Agenda
12:15 – 12:20
Welcome and Introduction
Marc A. Thill
12:20 – 12:30
Unlocking the Oncotype DX Breast Recurrence Score® Test:
Unique design and development to bring clarity to treatment decisions
Frédérique Penault-Llorca
12:30 – 12:45
Emerging Trends on Treatment Guidance in Early Breast Cancer:
Unveiling clinical implications from latest updates from TAILORx and RxPONDER
Christos Sotiriou
12:45 – 13:00
Advancing Treatment Approaches and Neoadjuvant Therapy in Early Breast Cancer:
Evidence-based strategies
Marc A. Thill
13:00 – 13:10
Q&A and Discussion
Marc A. Thill, Christos Sotiriou, Frédérique Penault-Llorca
13:10 – 13:15
Closing and Remarks
Marc A. Thill, Christos Sotiriou, Frédérique Penault-Llorca
ESMO Breast Cancer 2025 will take place in Munich, Germany, from 14 to 17 May 2025, as well as online, through a dedicated virtual platform.
This event brings together international experts in the field to explore the latest innovations, discuss cutting-edge treatments and collaborate on strategies to improve patient outcomes in breast cancer care.